文献速递肿瘤 PET/CT骨显像与常规 SPECT

963例新诊断前列腺癌患者分期68Ga-PSMA PET/CT中骨骼受累的发生率与特征

Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2021-12-27

单中心连续纳入963例新诊断前列腺癌并接受68Ga-PSMA-11 PET/CT分期,188例(19.5%)发现骨转移,其中广泛骨转移占7.6%、寡转移占11.9%;成骨型最常见(133例,70.7%),但髓内和溶骨型转移也常见,且GG≤2/3或PSA<10 ng/dL患者中亦可出现骨骼播散。

要点

  • 963例新诊断前列腺癌中188例(19.5%)存在骨转移。
  • 骨转移中广泛骨转移占7.6%、寡转移占11.9%。
  • 成骨型占133/188(70.7%),髓内型97例(51.6%),溶骨型36例(19.2%)。

核心结论

  • 尽管传统上前列腺癌骨转移被认为以成骨型为主,但68Ga-PSMA PET/CT显示溶骨型和髓内型转移也常见。
  • GG≤2/3和PSA<10 ng/dL的患者中也可能存在骨骼播散。

研究设计与样本

  • 单中心连续纳入963例新诊断前列腺癌并接受68Ga-PSMA-11 PET/CT分期的患者,分析骨受累发生率、骨转移类型及病变范围,并与ISUP分级分组(GG)标准和PSA水平进行关联。

主要发现

  • 963例中188例(19.5%)发现骨转移。
  • PSA<10 ng/dL患者中骨转移发生率为10.7%,PSA>10 ng/dL患者中为27.4%。
  • GG≤2/3患者中骨转移发生率为6.1%,GG 4/5患者中为8.9%。
  • 7.6%的患者骨骼受累广泛,11.9%的患者为寡转移。
  • 188例骨转移患者中,成骨型133例(70.7%),其中72例(38.3%)仅有成骨型病变,61例(32.5%)同时有髓内和/或溶骨型病变;髓内转移97例(51.6%),其中41例(21.8%)仅有髓内病变;溶骨型转移36例(19.2%),其中8例仅有溶骨型病变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The aim of the study was to elaborate the incidence and type of skeletal involvement in a large cohort of patients with newly diagnosed prostate cancer (PCa) referred for Ga-68 PSMA-11 PET/CT staging in a single center. METHODS: Study cohort included 963 consecutive patients with newly diagnosed PCa referred for Ga-68 PSMA-11 PET/CT study for staging. The incidence of bone involvement, type of bone metastases, and extent of disease were determined and correlated with the ISUP Grade Group (GG) criteria and PSA levels. RESULTS: Bone metastases were found in 188 (19.5%) of 963 patients. Bone metastases were found in 10.7% of patients with PSA < 10 ng/dL and in 27.4% of patients with PSA > 10 ng/dL and in 6.1% of patients with GG ≤ 2/3 and in 8.9% of patients with GG 4/5. In 7.6% of the patients, skeletal involvement was extensive, while 11.9% of patients had oligometastatic disease. Osteoblastic type metastases were the most common type of bone metastases presented in 133 of the patients with malignant bone involvement (70.7%). More than half of them had only osteoblastic lesions (72 patients (38.3%)), while the other (61 patients (32.5%)) had also intramedullary and/or osteolytic type lesions. Intramedullary metastases were found in 97 patients (51.6%), while 41 (21.8%) of them were only intramedullary lesions. Osteolytic metastases were detected in 36 patients (19.2%), of which 8 were only osteolytic lesions. CONCLUSION: Although traditionally bone metastases of PCa are considered osteoblastic, osteolytic and intramedullary metastases are common, as identified on PET with labeled PSMA. Skeletal spread may be present also in patients with GG ≤ 2/3 and PSA < 10 ng/dL.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Kesler M, Kerzhner K, Druckmann I, et al. Staging 68 Ga-PSMA PET/CT in 963 consecutive patients with newly diagnosed prostate cancer: incidence and characterization of skeletal involvement. Eur J Nucl Med Mol Imaging. 2021. PMID: 34957528. doi:10.1007/s00259-021-05655-y

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。